| Beginning - 04:43 | Welcome Amy Comstock Rick, J.D., Chief Executive Officer, Parkinson’s Action Network |
| 04:43 - 1:00:33 | How Government Affects Parkinson's Disease Fred Longenecker, Director of Regulatory Affairs, GE Healthcare Thomas Montine, M.D., Ph.D., Professor, Director of Neuropathology, Alvord Endowed Chair in Neuropathology, University of Washington Peter Schmidt, Ph.D., CIO and Vice President, Programs, National Parkinson Foundation Ann Wasson, California State Coordinator, Parkinson’s Action Network Moderator: Amy Comstock Rick, Chief Executive Officer, Parkinson’s Action Network |
| 1:00:33 - 1:30:15 | Keynote Address U.S. Senator Mark Udall (D-CO) Introduction: Amy Comstock Rick, Chief Executive Officer, Parkinson’s Action Network |
| 1:30:15 – 2:41:39 | How Advocacy Moves Government John Duda, M.D., Director, PADRECC, Philadelphia VA Medical Center; Assistant Professor of Neurology, University of Pennsylvania Kathy Hudson, Ph.D., Deputy Director for Science, Outreach, and Policy, National Institutes of Health James “J.P.” Paluskiewicz, Legislative Director, Representative Michael Burgess (R-TX) Michael Burgess, M.D. (R-TX) James Trussell, Georgia State Coordinator, Parkinson’s Action Network Moderator: John Schall, Deputy Chief Executive Officer, Parkinson’s Action Network |
| 2:41:39 – End | New Congress Update & Closing Remarks John Schall, Deputy Chief Executive Officer, Parkinson’s Action Network |